Holly B. Kordasiewicz
Evp, Chief Development Officer at Ionis Pharmaceuticals Inc (IONS)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $4.8M
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Jul 9SEC | IONSIonis Pharmaceuticals Inc | Sell Plan | 36222,096 held (−2%) | $84.30 | $31K | -46.3% |
| Jun 16SEC | IONSIonis Pharmaceuticals Inc | Sell Plan | 41,00442,300 held (−49%) | $73.09 | $3.0M | -38.0% |
| Jun 16SEC | IONSIonis Pharmaceuticals Inc | Sell Plan | 19,84222,458 held (−47%) | $74.05 | $1.5M | -38.9% |
| Jan 20SEC | IONSIonis Pharmaceuticals Inc | Sell | 4,14114,718 held (−22%) | $75.66 | $313K | -40.2% |
- Sell
Evp, Chief Development Officer Holly B. Kordasiewicz sold $31K of IONS at $84.30 — pre-scheduled 10b5-1 plan sale.
- Sell
Evp, Chief Development Officer Holly B. Kordasiewicz sold $3.0M of IONS at $73.09 — cuts the stake by 49%; pre-scheduled 10b5-1 plan sale.
- Sell
Evp, Chief Development Officer Holly B. Kordasiewicz sold $1.5M of IONS at $74.05 — cuts the stake by 47%; pre-scheduled 10b5-1 plan sale.